| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0027100 | Intron-Intron | chr3:172090508-172090777 | chr3:172372718-172372987 | 270 nt | 0.4778 |
| hsa_FNDC3B_0027200 | Exon-Exon | chr3:172096060-172096226 | chr3:172378270-172378436 | 167 nt | 0.5090 |
| hsa_FNDC3B_0027300 | Exon-Exon | chr3:172096060-172098883 | chr3:172378270-172381093 | 128 nt | 0.4063 |
| hsa_FNDC3B_0027400 | Exon-Exon | chr3:172096100-172115112 | chr3:172378310-172397322 | 414 nt | 0.4903 |
| hsa_FNDC3B_0027500 | Intron-Intron | chr3:172105394-172105592 | chr3:172387604-172387802 | 199 nt | 0.3920 |
| hsa_FNDC3B_0027600 | Intron-Intron | chr3:172108520-172108868 | chr3:172390730-172391078 | 349 nt | 0.4556 |
| hsa_FNDC3B_0027700 | Intron-Intron | chr3:172110271-172110484 | chr3:172392481-172392694 | 214 nt | 0.4252 |
| hsa_chr3_0369400 | Intergenic-Intergenic | chr3:172115931-172116181 | chr3:172398141-172398391 | 251 nt | 0.3227 |
| hsa_FNDC3B_0027800 | Exon-Exon | chr3:172116347-172116603 | chr3:172398557-172398813 | 257 nt | 0.4280 |
| hsa_FNDC3B_0027900 | Exon-Exon | chr3:172116741-172116985 | chr3:172398951-172399195 | 245 nt | 0.3265 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].